APA (7th ed.) Citation

Wada, M., Noda, Y., Iwata, Y., Tsugawa, S., Yoshida, K., Tani, H., . . . Nakajima, S. (2022). Dopaminergic dysfunction and excitatory/inhibitory imbalance in treatment-resistant schizophrenia and novel neuromodulatory treatment. Molecular Psychiatry, 27(7), 2950. https://doi.org/10.1038/s41380-022-01572-0

Chicago Style (17th ed.) Citation

Wada, Masataka, et al. "Dopaminergic Dysfunction and Excitatory/inhibitory Imbalance in Treatment-resistant Schizophrenia and Novel Neuromodulatory Treatment." Molecular Psychiatry 27, no. 7 (2022): 2950. https://doi.org/10.1038/s41380-022-01572-0.

MLA (9th ed.) Citation

Wada, Masataka, et al. "Dopaminergic Dysfunction and Excitatory/inhibitory Imbalance in Treatment-resistant Schizophrenia and Novel Neuromodulatory Treatment." Molecular Psychiatry, vol. 27, no. 7, 2022, p. 2950, https://doi.org/10.1038/s41380-022-01572-0.